Premium
Income related inequality in prescription drugs in Denmark
Author(s) -
Gundgaard Jens
Publication year - 2005
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.1039
Subject(s) - medical prescription , proxy (statistics) , medicine , inequality , consumption (sociology) , reimbursement , demographic economics , index (typography) , prescription drug , environmental health , health care , demography , economics , economic growth , statistics , sociology , mathematical analysis , social science , mathematics , world wide web , computer science , pharmacology
Purpose To examine income‐related inequity in utilisation of prescription drugs in Funen County, Denmark after a new reimbursement system was implemented. Methods An individual level prescription database was merged with a health survey of 2927 respondents interviewed in 2000 and 2001 about their health status and socio‐economic and socio‐demographic characteristics. An index of horizontal inequity was used to estimate the degree of inequity in drug utilisation across income groups, using the indirect method of standardisation to control for age, gender and health status as a proxy for need. The results were compared to estimates from a traditional regression analysis. Results The least advantaged with respect to income consume a bigger share of the prescription drugs than the most advantaged. After standardisation for age, gender and health status the least advantaged have a lower share of the drug consumption than expected. However, traditional regression analysis showed no signs of an income effect on the level of consumption of prescription drugs. Conclusions The index of horizontal inequity suggests that some horizontal inequity favouring the better off is present. However, the results deviate from what can be found by traditional regression analysis. Copyright © 2004 John Wiley & Sons, Ltd.